Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Iradimed Co(IRMD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for IRMD
11/11/2026: IRMD (1-star) is currently NOT-A-BUY. Pass it for now.
IRadimed Corporation is a specialized medical technology company that develops MRI-compatible infusion and monitoring systems. Its primary strength lies in its niche focus on safety in the MRI environment, which has historically supported robust profit margins. The company’s growth story revolves around the continued penetration of its existing products into hospitals and the potential for new accessory launches. However, investors must consider risks including product concentration, intense competition from large medical conglomerates, and regulatory hurdles. IRadimed may suit growth-oriented investors looking for specialized med-tech exposure, though it lacks the income appeal of dividend-paying stocks and carries the volatility typical of smaller-cap growth companies.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | IRadimed operates in a niche, expanding market with a high-margin business model. |
| Momentum investor | Mixed fit | The stock can exhibit momentum, though it is often subject to lower liquidity than larger-cap peers. |
| Value investor | Weak fit | The stock often trades at a premium multiple due to its niche market leadership and growth potential. |
| Dividend investor | Weak fit | The company does not pay a regular dividend, prioritizing growth reinvestment. |
| Low-risk investor | Weak fit | Small-cap medical device stocks are susceptible to higher volatility and regulatory risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Small-cap stocks in specialized industries often experience significant price swings. |
| Valuation risk | Medium / high | Investors often pay a premium for niche market leaders, leaving little room for error. |
| Competition risk (Large medical conglomerates) | Medium | Larger competitors could potentially introduce competing MRI-compatible devices. |
| Business quality | Strong | The company maintains high margins and a focus on essential safety equipment. |
| Dividend income | Low / none | Income-oriented investors will not find a yield here. |
| Execution risk | Medium | Maintaining R&D and regulatory compliance is vital to sustaining growth. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 10.01% | Avg. Invested days 48 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 11/11/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Sector & Industry Intelligence
Sector snapshot as of 2026-11-10
Sector
Healthcare
- Signal
- Constructive
- Sentiment
- Strong Bullish
- Market state
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 60.0%
- Active BUY / eligible
- 69 / 115
- 22-session BUY-count change
- +29
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Medical Devices
- BUY participation
- 57.1%
- Active BUY / eligible
- 4 / 7
- 22-session BUY-count change
- +1
The sector signal does not change this stock’s BUY, SELL, or PASS advisory.
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.11B USD | Price to earnings Ratio 46.37 | 1Y Target Price 118 |
Price to earnings Ratio 46.37 | 1Y Target Price 118 | ||
Volume (30-day avg) 123.9K shares | Beta 0.94 | 52 Weeks Range 76.35 - 107.20 | Updated Date 11/11/2026 |
52 Weeks Range 76.35 - 107.20 | Updated Date 11/11/2026 | ||
Dividends yield (FY) 0.92% | Basic EPS (TTM) 1.87 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Product Sales | Infusion pump systems and patient monitoring systems. | The company sells the actual medical devices to hospitals. |
| Services and Accessories | Replacement parts, maintenance services, and specialized MRI-safe disposables. | This provides recurring, reliable revenue after the initial sale. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-30 | When Before Market | Estimate 0.52 | Actual 0.51 |
Profitability
Profit Margin 26.85% | Operating Margin (TTM) 33.63% |
Management Effectiveness
Return on Assets (TTM) 15.3% | Return on Equity (TTM) 23.42% |
Valuation
Trailing PE 46.37 | Forward PE 35.59 | Enterprise Value 1.06B | Price to Sales(TTM) 12.41 |
Enterprise Value 1.06B | Price to Sales(TTM) 12.41 | ||
Enterprise Value to Revenue 11.88 | Enterprise Value to EBITDA 34.77 | Shares Outstanding 12.79M | Shares Floating 8.33M |
Shares Outstanding 12.79M | Shares Floating 8.33M | ||
Percent Insiders 35.18 | Percent Institutions 63.45 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.